GE HealthCare Unveils AI-Powered 3D Ultrasound System for Dense Breasts
The Invenia ABUS Premium device reportedly offers consistent high-resolution imaging and up to a 40 percent increase in scan speeds for women with dense breasts.
For women with dense breasts, the newly launched Invenia ABUS Premium device offers a combination of artificial intelligence (AI) tools and enhanced 3D ultrasound imaging quality to facilitate detection and characterization of breast lesions.
In addition to automated breast ultrasound (ABUS) technology that aids in the detection of malignancies, the Invenia ABUS Premium device offers AI tools such as Scan Quality Assessment, which helps ensure proper coverage and positioning of breasts for scanning, and Auto Nipple Detection for enabling consistent nipple marker positions, according to GE HealthCare, the developer of the Invenia ABUS Premium platform.
Improved imaging resolution with the recently launched Invenia ABUS Premium system reveals smaller hypoechoic lesions in the above case. (Images courtesy of GE HealthCare.)
The company added that a Fast Scan tool with the Invenia ABUS Premium device provides up a 40 percent increase in scan speed, and a combination of the Invenia ABUS Viewer with AI Assistant allows expeditious review and assessment of ultrasound exams.
“Women with dense breasts often face poorer outcomes due to malignancies detected at later, more advanced stages. Invenia ABUS Premium equipped with AI has the potential to optimize clinicians’ screening capabilities, enabling them to detect even small, early-stage cancers with a high degree of confidence in women with dense breasts,” said Karley Yoder, the CEO of Comprehensive Care Ultrasound at GE HealthCare.
GE HealthCare said another key feature with the Invenia ABUS Premium system is the Reverse Curve tranducer, which offers one to maximize patient comfort with selectable compression levels and enables more precise contouring of breast anatomy.
“The new Reverse Curve transducer makes the examination more patient friendly, and it is much more comfortable. There has been great improvement in image quality with less shadowing, and the structures behind the area of the nipple are seen more clearly, providing radiologists with greater diagnostic confidence,” added Athina Vourtsis, M.D., Ph.D, the chief director and founder of Athena Medical in Athens, Greece, and a member of the medical advisory board for DenseBreast-Info.org .
Recent Videos
Related Content
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025Article
In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Podcast
Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025Article
In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
